Skyrizi 150 MG/ML penml
Ended Awarded Last action
- Contract number
- SPE2DR26FL005
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $50,239
Award facts
- Contract value 100% obligated
- $50,239.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $50,239.25 firm fixed-price delivery order to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/ml pen, a pharmaceutical product used in the treatment of immunological conditions. The award, issued on January 21, 2026, with an ultimate completion date of January 22, 2026, represents a non-set-aside competitive award. This delivery order is executed under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), which serves as the primary vehicle for supplying pharmaceutical products and medical supplies to military healthcare programs globally. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a subsidiary of parent company Cencora, Inc., and functions as a critical vendor in the federal medical procurement supply chain.
The delivery order will be performed at the contractor's facility in Conshohocken, Pennsylvania. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp maintains an extensive portfolio of federal contracts supporting military and veteran healthcare systems through the DLA Medical Supply Chain. The company's capabilities encompass a comprehensive range of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains, positioning it as a key supplier for Department of Defense healthcare requirements.
Quick answers
Who was awarded contract SPE2DR26FL005?
SPE2DR26FL005 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26FL005 worth?
The government has obligated $50,239 on SPE2DR26FL005.
Is contract SPE2DR26FL005 an order under another contract?
Yes. SPE2DR26FL005 is a delivery order under SPE2DR25D1104, an indefinite delivery contract.
Was contract SPE2DR26FL005 competed?
The extent of competition for SPE2DR26FL005 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award